Autophagy Defects in Skeletal Myopathies
Author:
- 24 January 2020
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pathology: Mechanisms of Disease
- Vol. 15 (1) , 261-285
Abstract
Autophagy is an evolutionarily conserved catabolic process that targets different types of cytoplasmic cargo (such as bulk cytoplasm, damaged cellular organelles, and misfolded protein aggregates) for lysosomal degradation. Autophagy is activated in response to biological stress and also plays a critical role in the maintenance of normal cellular homeostasis; the latter function is particularly important for the integrity of postmitotic, metabolically active tissues, such as skeletal muscle. Through impairment of muscle homeostasis, autophagy dysfunction contributes to the pathogenesis of many different skeletal myopathies; the observed autophagy defects differ from disease to disease but have been shown to involve all steps of the autophagic cascade (from induction to lysosomal cargo degradation) and to impair both bulk and selective autophagy. To highlight the molecular and cellular mechanisms that are shared among different myopathies with deficient autophagy, these disorders are discussed based on the nature of the underlying autophagic defect rather than etiology or clinical presentation.Keywords
This publication has 121 references indexed in Scilit:
- Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal diseaseEMBO Molecular Medicine, 2013
- Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseEMBO Molecular Medicine, 2013
- Alterations in ROS Activity and Lysosomal pH Account for Distinct Patterns of Macroautophagy in LINCL and JNCL FibroblastsPLOS ONE, 2013
- Autophagy as a new therapeutic target in Duchenne muscular dystrophyCell Death & Disease, 2012
- Autophagy in lysosomal storage disordersAutophagy, 2012
- The emerging phenotype of long-term survivors with infantile Pompe diseaseGenetics in Medicine, 2012
- Quantitation of "autophagic flux" in mature skeletal muscleAutophagy, 2010
- FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end–directed vesicle transportJournal of Cell Biology, 2010
- Control of autophagy initiation by phosphoinositide 3‐phosphatase jumpyThe EMBO Journal, 2009
- Protective Effect of Geranylgeranylacetone via Enhancement of HSPB8 Induction in Desmin-Related CardiomyopathyPLOS ONE, 2009